Literature DB >> 11711120

Pharmacology and biochemistry of spider venoms.

Lachlan D Rash1, Wayne C Hodgson.   

Abstract

Spider venoms represent an incredible source of biologically active substances which selectively target a variety of vital physiological functions in both insects and mammals. Many toxins isolated from spider venoms have been invaluable in helping to determine the role and diversity of neuronal ion channels and the process of exocytosis. In addition, there is enormous potential for the use of insect specific toxins from animal sources in agriculture. For these reasons, the past 15-20 years has seen a dramatic increase in studies on the venoms of many animals, particularly scorpions and spiders. This review covers the pharmacological and biochemical activities of spider venoms and the nature of the active components. In particular, it focuses on the wide variety of ion channel toxins, novel non-neurotoxic peptide toxins, enzymes and low molecular weight compounds that have been isolated. It also discusses the intraspecific sex differences in given species of spiders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11711120     DOI: 10.1016/s0041-0101(01)00199-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  58 in total

1.  From a pump to a pore: how palytoxin opens the gates.

Authors:  Donald W Hilgemann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

2.  Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake.

Authors:  Andréia Cristina Karklin Fontana; Renato Guizzo; Renê de Oliveira Beleboni; Antonio Renato Meirelles E Silva; Norberto Cysne Coimbra; Susan G Amara; Wagner Ferreira dos Santos; Joaquim Coutinho-Netto
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 3.  Venom effects on monoaminergic systems.

Authors:  Aviva Weisel-Eichler; Frederic Libersat
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-05-25       Impact factor: 1.836

4.  Novel class of spider toxin: active principle from the yellow sac spider Cheiracanthium punctorium venom is a unique two-domain polypeptide.

Authors:  Alexander A Vassilevski; Irina M Fedorova; Ekaterina E Maleeva; Yuliya V Korolkova; Svetlana S Efimova; Olga V Samsonova; Ludmila V Schagina; Alexei V Feofanov; Lev G Magazanik; Eugene V Grishin
Journal:  J Biol Chem       Date:  2010-07-24       Impact factor: 5.157

5.  Unique bell-shaped voltage-dependent modulation of Na+ channel gating by novel insect-selective toxins from the spider Agelena orientalis.

Authors:  Bert Billen; Alexander Vassilevski; Anton Nikolsky; Sarah Debaveye; Jan Tytgat; Eugene Grishin
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

Review 6.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

7.  Chemical punch packed in venoms makes centipedes excellent predators.

Authors:  Shilong Yang; Zhonghua Liu; Yao Xiao; Yuan Li; Mingqiang Rong; Songping Liang; Zhiye Zhang; Haining Yu; Glenn F King; Ren Lai
Journal:  Mol Cell Proteomics       Date:  2012-05-17       Impact factor: 5.911

Review 8.  Tarantula toxins interacting with voltage sensors in potassium channels.

Authors:  Kenton J Swartz
Journal:  Toxicon       Date:  2006-09-29       Impact factor: 3.033

Review 9.  Molecular diversification in spider venoms: a web of combinatorial peptide libraries.

Authors:  Pierre Escoubas
Journal:  Mol Divers       Date:  2006-11-10       Impact factor: 2.943

10.  Target promiscuity and heterogeneous effects of tarantula venom peptides affecting Na+ and K+ ion channels.

Authors:  Elisa Redaelli; Rita Restano Cassulini; Deyanira Fuentes Silva; Herlinda Clement; Emanuele Schiavon; Fernando Z Zamudio; George Odell; Annarosa Arcangeli; Jeffrey J Clare; Alejandro Alagón; Ricardo C Rodríguez de la Vega; Lourival D Possani; Enzo Wanke
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.